|
1
|
Y YonemuraY EndouT SasakiM HiranoA
MizumotoT MatsudaN TakaoM IchinoseM MiuraY LiSurgical treatment for
peritoneal carcinomatosis from gastric cancerEur J Surg
Oncol3611311138201010.1016/j.ejso.2010.09.00620933363
|
|
2
|
A JemalR SiegelE WardY HaoJ XuMJ
ThunCancer statistics, 2009CA Cancer J
Clin59225249200910.3322/caac.20006
|
|
3
|
H KawaidaK KonoA TakahashiH SugaiK MimuraN
MiyagawaH OmataA OoiH FujiiDistribution of
CD4+CD25(high) regulatory T-cells in tumor-draining
lymph nodes in patients with gastric cancerJ Surg
Res1241511572005
|
|
4
|
S GrossP WaldenImmunosuppressive
mechanisms in human tumors: Why we still cannot cure cancerImmunol
Lett116714200810.1016/j.imlet.2007.11.01218164076
|
|
5
|
K HirokawaM UtsuyamaT IshikawaY KikuchiM
KitagawaY FujiiH NariuchiH UetakeK SugiharaDecline of T
cell-related immune functions in cancer patients and an attempt to
restore them through infusion of activated autologous T cellsMech
Ageing Dev1308691200910.1016/j.mad.2008.05.00118555517
|
|
6
|
JK PettyK HeCL CorlessJT VettoAD
WeinbergSurvival in human colorectal cancer correlates with
expression of the T-cell costimulatory molecule OX-40 (CD134)Am J
Surg183512518200210.1016/S0002-9610(02)00831-012034383
|
|
7
|
N TedlaCW LeeL BorgesCL GeczyJP
ArmDifferential expression of leukocyte immunoglobulin-like
receptors on cord-blood-derived human mast cell progenitors and
mature mast cellsJ Leukoc
Biol83334343200810.1189/jlb.050731417998301
|
|
8
|
CA GleissnerTJ DenglerInduction of ILT
expression on nonprofessional antigen presenting cells: clinical
applicationsHum
Immunol70357359200910.1016/j.humimm.2009.01.02519405175
|
|
9
|
A Monsivais-UrendaP Nino-MorenoC
Abud-MendozaL BarandaE Layseca-EspinosaM Lopez-BotetR
Gonzalez-AmaroAnalysis of expression and function of the inhibitory
receptor ILT2 (CD85j/LILRB1/LIR-1) in peripheral blood mononuclear
cells from patients with systemic lupus erythematosus (SLE)J
Autoimmun2997105200710.1016/j.jaut.2007.05.00317601702
|
|
10
|
H NakajimaJ SamaridisL AngmanM
ColonnaCutting edge: human myeloid cells express an activating ILT
receptor (ILT1) that associates with Fc receptor gamma-chainJ
Immunol1625819999886363
|
|
11
|
M CellaC DohringJ SamaridisM DessingM
BrockhausA LanzavecchiaM ColonnaA novel inhibitory receptor (ILT3)
expressed on monocytes, macrophages, and dendritic cells involved
in antigen processingJ Exp
Med18517431751199710.1084/jem.185.10.1743
|
|
12
|
X XuP ZouL ChenG JinH ZhouIL-10 enhances
promoter activity of ILT4 gene and up-regulates its expression in
THP-1 cellsJ Huazhong Univ Sci Technolog Med
Sci30594598201010.1007/s11596-010-0548-821063840
|
|
13
|
H WendeA VolzA ZieglerExtensive gene
duplications and a large inversion characterize the human leukocyte
receptor
clusterImmunogenetics51703713200010.1007/s00251000018710941842
|
|
14
|
M TorkarZ NorgateM ColonnaJ TrowsdaleMJ
WilsonIsotypic variation of novel immunoglobulin-like
transcript/killer cell inhibitory receptor loci in the leukocyte
receptor complexEur J
Immunol2839593967199810.1002/(SICI)1521-4141(199812)28:12%3C3959::AID-IMMU3959%3E3.0.CO;2-29862332
|
|
15
|
Y ChenF ChuF GaoB ZhouGF GaoStability
engineering, biophysical, and biological characterization of the
myeloid activating receptor immunoglobulin-like transcript 1
(ILT1/LIR-7/LILRA2)Protein Expr
Purif56253260200710.1016/j.pep.2007.08.010
|
|
16
|
AH BanhamM ColonnaM CellaKJ MicklemK
PulfordAC WillisDY MasonIdentification of the CD85 antigen as ILT2,
an inhibitory MHC class I receptor of the immunoglobulin
superfamilyJ Leukoc Biol65841845199910380908
|
|
17
|
E MorelT BellonAmoxicillin conjugates to
HLA class I molecules and interferes with signalling through the
ILT2/LIR-1/CD85j inhibitory
receptorAllergy62190196200710.1111/j.1398-9995.2006.01285.x
|
|
18
|
AI ColovaiL TsaoS WangH LinC WangT SekiJG
FisherM MenesG BhagatB AlobeidN Suciu-FocaExpression of inhibitory
receptor ILT3 on neoplastic B cells is associated with lymphoid
tissue involvement in chronic lymphocytic leukemiaCytometry B Clin
Cytom72354362200710.1002/cyto.b.2016417266150
|
|
19
|
S Kim-SchulzeT SekiG VladL ScottoJ FanRC
ColomboJ LiuR CortesiniN Suciu-FocaRegulation of ILT3 gene
expression by processing of precursor transcripts in human
endothelial cellsAm J
Transplant67682200610.1111/j.1600-6143.2005.01162.x16433759
|
|
20
|
JV RavetchLL LanierImmune inhibitory
receptorsScience2908489200010.1126/science.290.5489.84
|
|
21
|
CS ChuiD LiRole of immuno-lglobulin-like
transcript family receptors and their ligands in suppressor
T-cell-induced dendritic cell tolerizationHum
Immunol70686691200910.1016/j.humimm.2009.06.00319524004
|
|
22
|
DP BrownDC JonesKJ AndersonN LapaqueRA
BuerkiJ TrowsdaleRL AllenThe inhibitory receptor LILRB4 (ILT3)
modulates antigen presenting cell phenotype and, along with LILRB2
(ILT4), is upregulated in response to Salmonella infectionBMC
Immunol1056200910.1186/1471-2172-10-5619860908
|
|
23
|
LE PilsburyRL AllenM VordermeierModulation
of Toll-like receptor activity by leukocyte Ig-like receptors and
their effects during bacterial infectionMediators
Inflamm2010536478201010.1155/2010/53647820634939
|
|
24
|
G VladJ KingCC ChangZ LiuRA FriedmanAA
TorkamaniN Suciu-FocaGene profile analysis of CD8+
ILT3-Fc induced T suppressor cellsHum
Immunol72107114201110.1016/j.humimm.2010.10.01220974207
|
|
25
|
G VladR CortesiniN
Suciu-FocaCD8+ T suppressor cells and the ILT3 master
switchHum Immunol696816862008
|
|
26
|
JY ZhangAK SomaniKA SiminovitchRoles of
the SHP-1 tyrosine phosphatase in the negative regulation of cell
signallingSemin
Immunol12361378200010.1006/smim.2000.022310995583
|
|
27
|
M ColonnaH NakajimaM CellaA family of
inhibitory and activating Ig-like receptors that modulate function
of lymphoid and myeloid cellsSemin
Immunol12121127200010.1006/smim.2000.021410764620
|
|
28
|
S LefebvreM AntoineS UzanM McMasterJ
DaussetED CarosellaP PaulSpecific activation of the non-classical
class I histocompatibility HLA-G antigen and expression of the ILT2
inhibitory receptor in human breast cancerJ
Pathol196266274200210.1002/path.103911857488
|
|
29
|
B FedoricR KrishnanRapamycin downregulates
the inhibitory receptors ILT2, ILT3, ILT4 on human dendritic cells
and yet induces T cell hyporesponsiveness independent of FoxP3
inductionImmunol Lett1204956200810.1016/j.imlet.2008.06.009
|
|
30
|
B FavierJ LemaoultE LesportED
CarosellaILT2/HLA-G interaction impairs NK-cell functions through
the inhibition of the late but not the early events of the NK-cell
activating synapseFASEB
J24689699201010.1096/fj.09-13519419841038
|
|
31
|
V HofmeisterEH WeissHLA-G modulates immune
responses by diverse receptor interactionsSemin Cancer
Biol13317323200310.1016/S1044-579X(03)00022-114708711
|
|
32
|
XS JuC HackerB SchererV RedeckeT BergerG
SchulerH WagnerGB LipfordM ZenkeImmunoglobulin-like transcripts
ILT2, ILT3 and ILT7 are expressed by human dendritic cells and
down-regulated following
activationGene331159164200410.1016/j.gene.2004.02.01815094202
|
|
33
|
M ShiroishiK TsumotoK AmanoY ShirakiharaM
ColonnaVM BraudDS AllanA MakadzangeS Rowland-JonesB WillcoxEY
JonesPA van der MerweI KumagaiK MaenakaHuman inhibitory receptors
Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class
I binding and bind preferentially to HLA-GProc Natl Acad Sci
USA10088568861200310.1073/pnas.143105710012853576
|
|
34
|
JS ManavalanPC RossiG VladF PiazzaA
YarilinaR CortesiniD ManciniN Suciu-FocaHigh expression of ILT3 and
ILT4 is a general feature of tolerogenic dendritic cellsTranspl
Immunol11245258200310.1016/S0966-3274(03)00058-312967778
|
|
35
|
J WuA HoruzskoExpression and function of
immunoglobulin-like transcripts on tolerogenic dendritic cellsHum
Immunol70353356200910.1016/j.humimm.2009.01.02419405174
|
|
36
|
U SvajgerA VidmarM JerasNiflumic acid
renders dendritic cells tolerogenic and up-regulates inhibitory
molecules ILT3 and ILT4Int
Immunopharmacol89971005200810.1016/j.intimp.2008.03.00618486911
|
|
37
|
N Suciu-FocaR CortesiniCentral role of
ILT3 in the T suppressor cell cascadeCell
Immunol2485967200710.1016/j.cellimm.2007.01.01317923119
|
|
38
|
I TamirJM Dal PortoJC CambierCytoplasmic
protein tyrosine phosphatases SHP-1 and SHP-2: regulators of B cell
signal transductionCurr Opin
Immunol12307315200010.1016/S0952-7915(00)00092-310781410
|
|
39
|
LS TaamsJM van AmelsfortMM TiemessenKM
JacobsEC de JongAN AkbarJW BijlsmaFP LafeberModulation of
monocyte/macrophage function by human
CD4+CD25+ regulatory T cellsHum
Immunol66222230200510.1016/j.humimm.2004.12.00615784460
|
|
40
|
A MunitzInhibitory receptors on myeloid
cells: New targets for therapy?Pharmacol
Ther125128137201010.1016/j.pharmthera.2009.10.00719913051
|
|
41
|
J LeitnerK Grabmeier-PfistershammerP
SteinbergerReceptors and ligands implicated in human T cell
costimulatory processesImmunol
Lett1288997201010.1016/j.imlet.2009.11.00919941899
|
|
42
|
YP SunJ LiuP GaoYS WangCY LiuExpression of
Ig-like transcript 4 inhibitory receptor in human non-small cell
lung cancerChest134783788200810.1378/chest.07-110018625675
|
